Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Ho

Showing results (101-110 of 190) with videos related to

Pageof 19
Sort By:
Health and Quality of Life Outcomes|February 19, 2020
Measurement invariance across gender and age groups, validity and reliability of the Chinese version of the short-form supportive care needs survey questionnaire (SCNS-SF34)Edmond Pui Hang Choi, Qiuyan Liao, Inda Soong, et al.
Cancers|January 23, 2024
Shift in Tissue-Specific Immune Niches and CD137 Expression in Tuberculoma of Pembrolizumab-Treated Nasopharyngeal Carcinoma PatientsNgar Woon Kam, Anthony Wing Ip Lo, Desmond Tae Yang Hung, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2023
Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatmentVictor Ho-Fun Lee, Sik-Kwan Chan, Yiu-Ho Tam, et al.
Journal of Advanced Research|April 15, 2023
ENOX2 inhibition enhances infiltration of effector memory T-cell and mediates response to chemotherapy in immune-quiescent nasopharyngeal carcinomaNgar-Woon Kam, Olivier Laczka, Xiang Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 18, 2014
Power factor enhancement in solution-processed organic n-type thermoelectrics through molecular designBoris Russ, Maxwell J Robb, Fulvio G Brunetti, et al.
Frontiers in Oncology|May 16, 2022
A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of CisplatinZhiyuan Xu, Li Yang, Wai-Tong Ng, et al.
Carcinogenesis|November 6, 2012
MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTENLi-Yi Zhang, Victor Ho-Fun Lee, Alissa Michelle Go Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Deep Learning-Based Motion-Compensated Reconstruction for Accelerating 4-Dimensional Magnetic Resonance FingerprintingLu Wang, Chenyang Liu, Yinghui Wang, et al.
Oral Oncology|January 28, 2021
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studiesSik-Kwan Chan, Sum-Yin Chan, Chi-Chung Tong, et al.
Frontiers in Oncology|March 15, 2021
The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-AnalysisHorace Cheuk-Wai Choi, Sik-Kwan Chan, Ka-On Lam, et al.
Pageof 19

Showing results (101-110 of 190) with videos related to

Sort By:
Pageof 19
Health and Quality of Life Outcomes|February 19, 2020
Measurement invariance across gender and age groups, validity and reliability of the Chinese version of the short-form supportive care needs survey questionnaire (SCNS-SF34)Edmond Pui Hang Choi, Qiuyan Liao, Inda Soong, et al.
Cancers|January 23, 2024
Shift in Tissue-Specific Immune Niches and CD137 Expression in Tuberculoma of Pembrolizumab-Treated Nasopharyngeal Carcinoma PatientsNgar Woon Kam, Anthony Wing Ip Lo, Desmond Tae Yang Hung, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2023
Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatmentVictor Ho-Fun Lee, Sik-Kwan Chan, Yiu-Ho Tam, et al.
Journal of Advanced Research|April 15, 2023
ENOX2 inhibition enhances infiltration of effector memory T-cell and mediates response to chemotherapy in immune-quiescent nasopharyngeal carcinomaNgar-Woon Kam, Olivier Laczka, Xiang Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 18, 2014
Power factor enhancement in solution-processed organic n-type thermoelectrics through molecular designBoris Russ, Maxwell J Robb, Fulvio G Brunetti, et al.
Frontiers in Oncology|May 16, 2022
A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of CisplatinZhiyuan Xu, Li Yang, Wai-Tong Ng, et al.
Carcinogenesis|November 6, 2012
MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTENLi-Yi Zhang, Victor Ho-Fun Lee, Alissa Michelle Go Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Deep Learning-Based Motion-Compensated Reconstruction for Accelerating 4-Dimensional Magnetic Resonance FingerprintingLu Wang, Chenyang Liu, Yinghui Wang, et al.
Oral Oncology|January 28, 2021
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studiesSik-Kwan Chan, Sum-Yin Chan, Chi-Chung Tong, et al.
Frontiers in Oncology|March 15, 2021
The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-AnalysisHorace Cheuk-Wai Choi, Sik-Kwan Chan, Ka-On Lam, et al.
Pageof 19